100 Recruiting Studies Using Paclitaxel

Active clinical trials that use this intervention, sourced directly from the NIH registry.

Browse by condition

Trials Using Paclitaxel

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients

📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska

Anal Basaloid Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

📍 Regional Medical Center — Anniston, Alabama

Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)

📍 Highlands Oncology Group - Springdale /ID# 270290 — Springdale, Arkansas

Urothelial Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

📍 University of Chicago — Chicago, Illinois

Human Papilloma Virus

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

📍 City of Hope Corona — Corona, California

FIGO Stage IVA Ovarian Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)

📍 University of Alabama at Birmingham-Medicine ( Site 0065) — Birmingham, Alabama

Breast Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Observational / Diagnostic 💊 Investigational Drug / Biologic

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Stage IB Lung Non-Small Cell Carcinoma AJCC v7

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Borderline Ovarian Mucinous Tumor

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

📍 UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California

Fallopian Tube Endometrioid Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study

📍 University of Colorado Cancer Center — Aurora, Colorado

Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)

📍 Banner MD Anderson Cancer Center ( Site 0119) — Gilbert, Arizona

Gastroesophageal Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer

📍 BCCA - Vancouver Cancer Centre — Vancouver, British Columbia

Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

📍 USA Mitchell Cancer Institute ( Site 4142) — Mobile, Alabama

Endometrial Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

📍 University of Miami Sylvester Comprehensive Cancer Center — Miami, Florida

Breast Cancer Metastatic

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer

📍 Research Site — Tucson, Arizona

Triple Negative Breast Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]

📍 Cedars Sinai Medical Center — Los Angeles, California

HER2-positive Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Testing the Use of Nilotinib and Paclitaxel as a Treatment for Patients With Prior Taxane Treatment, A ComboMATCH Treatment Trial

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Metastatic Malignant Solid Neoplasm

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)

📍 M D Anderson Cancer Center — Houston, Texas

Stage III Fallopian Tube Cancer AJCC v7

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma

📍 Washington University School of Medicine — St Louis, Missouri

Cutaneous Angiosarcoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer

📍 M D Anderson Cancer Center — Houston, Texas

Metastatic Thyroid Gland Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska

Metastatic Cholangiocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

📍 Moffitt Cancer Center-International Plaza — Tampa, Florida

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Fallopian Tube Clear Cell Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors

📍 HonorHealth Research Institute — Scottsdale, Arizona

Solid Tumor

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

📍 Southern Cancer Care — Daphne, Alabama

NSCLC

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)

📍 Research Site — Anaheim, California

Non Small Cell Lung Carcinoma NSCLC

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy

📍 Los Angeles General Medical Center — Los Angeles, California

Metastatic Lung Non-Small Cell Squamous Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer

📍 Froedtert Hospital & Medical College of Wisconsin — Milwaukee, Wisconsin

Invasive Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Fallopian Tube Clear Cell Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer

📍 M D Anderson Cancer Center — Houston, Texas

Breast Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

MPDL3280A With Chemoradiation for Lung Cancer

📍 MD Anderson Cancer Center — Houston, Texas

Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

📍 Research Site — Tucson, Arizona

Endometrial Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer

📍 Washington University School of Medicine — St Louis, Missouri

Esophagus Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)

📍 Research Site — Duarte, California

Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

📍 Veterans Administration Medical Center - Birmingham — Birmingham, Alabama

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

📍 Innovative Clinical Research Institute — Whittier, California

Non-small Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer

📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania

Esophageal Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer

📍 Research Site — Columbus, Georgia

Non Small Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

📍 Arizona Oncology Associates, PC-Hope,1845 W Orange Grove Rd — Tucson, Arizona

Triple Negative Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer

📍 Johns Hopkins University — Baltimore, Maryland

Gastric Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer

📍 BRCR Medical Center Inc. — Plantation, Florida

HER2-positive Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer

📍 Research Site — Springdale, Arkansas

Breast Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

📍 Beverly Hills Cancer Center — Beverly Hills, California

Locally Advanced Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

📍 Clermont Oncology Center — Clermont, Florida

Resectable Non-small Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

📍 Local Institution - 0104 — Tampa, Florida

Carcinoma, Non-Small-Cell Lung

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Study of INCB123667 in Subjects With Advanced Solid Tumors

📍 City of Hope Medical Center — Duarte, California

Solid Tumors

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

'ADVANCE' (A Pilot Trial)

📍 City of Hope National Medical Center — Duarte, California

Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer

📍 UCSF Medical Center-Mission Bay — San Francisco, California

Fallopian Tube Endometrioid Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

📍 Alaska Oncology and Hematology LLC — Anchorage, Alaska

Malignant Solid Tumor

View Study & Checklist ➔

🔵 Active, Not Recruiting Early Phase1 💊 Investigational Drug / Biologic

Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer

📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey

Anaplastic Thyroid Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

HOT: HIPEC in Ovarian Cancer as Initial Treatment

📍 Mercy Medical Center — Baltimore, Maryland

Stage III Ovarian Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

📍 Arizona Clinical Research Center, Inc — Tucson, Arizona

Locally Advanced or Metastatic Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

📍 Northeast Alabama Regional Medical Center — Anniston, Alabama

Breast Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer

📍 Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey

Estrogen Receptor-negative Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer

📍 University of Illinois — Chicago, Illinois

Triple Negative Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

📍 City of Hope Medical Center — Duarte, California

Pancreatic Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer

📍 Research Site — Commack, New York

Metastatic Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Observational / Diagnostic 💊 Investigational Drug / Biologic

Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

📍 Jonsson Comprehensive Cancer Center — Los Angeles, California

Adenocarcinoma of the Lung

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey

Metastatic Esophageal Carcinoma

View Study & Checklist ➔

ACTIVE_NOT_RECRUITING phase2 Protocol

Volrustomig Priming Regimens Exploratory Phase II Platform Study

📍 Research Site — Los Angeles, California

Non-small Cell Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

📍 Research Site — Phoenix, Arizona

NSCLC

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer

📍 Research Site — Daphne, Alabama

Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC

📍 Research Site — Whittier, California

Triple Negative Breast Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer

📍 Princess Margaret Cancer Centre — Toronto, Ontario

Recurrent Ovarian Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor

📍 UAMS — Little Rock, Arkansas

Endometrial Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery

📍 City of Hope Comprehensive Cancer Center — Duarte, California

Advanced Esophageal Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

📍 Mayo Clinic in Arizona — Scottsdale, Arizona

Metastatic Esophageal Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

📍 HonorHealth-USOR HonorHealth ( Site 8000) — Phoenix, Arizona

Endometrial Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

📍 Saint Joseph's Hospital and Medical Center — Phoenix, Arizona

Endometrial Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)

📍 University of Alabama Birmingham — Birmingham, Alabama

Epithelial Ovarian Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

📍 Honor Health — Phoenix, Arizona

Carcinoma, Ovarian Epithelial

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

📍 University of Alabama - Birmingham ( Site 3061) — Birmingham, Alabama

Endometrial Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).

📍 Comprehensive Blood and Cancer Center — Bakersfield, California

Thoracic Tumors

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

📍 Ironwood Cancer & Research Centers - Chandler II — Chandler, Arizona

Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab

📍 UC Irvine Health/Chao Family Comprehensive Cancer Center — Orange, California

Breast Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio

Platinum-Resistant Fallopian Tube Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

📍 Wake Forest Baptist Health Sciences — Winston-Salem, North Carolina

Head Neck Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01

📍 Siteman Cancer Center — St Louis, Missouri

Head and Neck Squamous Cell Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)

📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas

Endometrial Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

📍 University of Pennsylvania Hospital — Philadelphia, Pennsylvania

Breast Neoplasm

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy

📍 Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers — Chandler, Arizona

Locally Advanced or Unresectable Metastatic Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Anatomic Stage II Breast Cancer AJCC v8

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer

📍 University of Texas MD Anderson Cancer Center — Houston, Texas

Advanced Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Early Phase1 💊 Investigational Drug / Biologic

TAME: A Pilot Study of Weekly Paclitaxel, Bevacizumab, and Tumor Associated Macrophage Targeted Therapy (Zoledronic Acid) in Women With Recurrent, Platinum-resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

📍 M D Anderson Cancer Center — Houston, Texas

Epithelial Ovarian

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma

📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona

Skin Angiosarcoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC

📍 Holden Comprehensive Cancer Cener — Iowa City, Iowa

Carcinoma, Non-Small-Cell Lung

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska

Low Grade Fallopian Tube Serous Adenocarcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Study of Novel Treatment Combinations in Patients With Lung Cancer

📍 Arizona Oncology Associates,Substudy-02 — Tucson, Arizona

Lung Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors

📍 UCSF Helen Diller Family CCC — San Francisco, California

Ovarian Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

📍 Southern Cancer Center, PC ( Site 8003) — Daphne, Alabama

Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer

📍 Research Site — Fort Myers, Florida

Metastatic Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)

📍 Research Site — Anaheim, California

Non Small Cell Lung Carcinoma NSCLC

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

📍 Sibley Memorial Hospital — Washington D.C., District of Columbia

Triple Negative Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic

DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC

📍 Massachusetts General Hospital — Boston, Massachusetts

Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer

📍 GSK Investigational Site — Phoenix, Arizona

Neoplasms

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer

📍 Research Site — Stanford, California

Ovarian Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

📍 Alaska Oncology and Hematology — Anchorage, Alaska

Triple Negative Breast Cancer

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona

Invasive Breast Carcinoma

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

📍 University of Florida Health Science Center - Jacksonville — Jacksonville, Florida

Stage II Non-Small Cell Lung Cancer AJCC v7

View Study & Checklist ➔